Color Study (High-Risk Breast Lesions) - Clinical Trial

What is the Purpose of this Study?


If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test

What is the Condition Being Studied?

Genetic Testing

Who Can Participate in the Study?

Key Eligibility

Women diagnosed with high-risk breast lesions including:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)

Age Group

What is Involved?


We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

Study Details

Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00089223
NCT: NCT00000000
Phase N/A
Enrollment Status
Open for Enrollment